Crossmark

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study

Crossref DOI link: https://doi.org/10.1186/s12882-019-1318-x

Published Online: 2019-04-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pei, Ming

Aguiar, Rute

Pagels, Agneta A.

Heimbürger, Olof

Stenvinkel, Peter

Bárány, Peter

Medin, Charlotte

Jacobson, Stefan H.

Hylander, Britta

Lindholm, Bengt

Qureshi, Abdul Rashid https://orcid.org/0000-0003-0536-5327
Funding

Funding for this research was provided by:

Baxter Healthcare Corporation

Amgen Foundation

Medicinska Forskningsrådet

Martin Rinds Stiftelse
License Information

Text and Data Mining valid from 2019-04-29
More Information

Article History

Received: 13 September 2018

Accepted: 29 March 2019

First Online: 29 April 2019

Ethics approval and consent to participate

: Each participant provided written informed consent, and the institutional review board at Karolinska Institutet, Stockholm, approved the protocol.

: Not applicable.

: Bengt Lindholm is affiliated with Baxter Healthcare Corporation. None of the other authors declare any competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.